The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Ameritas Advisory Services LLC’s holdings in Pfizer were worth $2,016,000 at ... and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers ...

Even when broadly upholding that responsibility, it's still very possible to miss the forest for the trees, as I did with Pfizer (NYSE: PFE). Since roughly 2020, my investment thesis called for Pfizer ...

Pfizer said a late-stage study of its sasanlimab ... We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

The final four dividend stocks to buy and hold in 2025 are a mixed assortment. The common denominators between these stocks include that they have solid businesses built for the long term and they all ...

FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.